CTC Firm On-Q-ity Closes Shop | GenomeWeb

NEW YORK (GenomeWeb News) – Circulating tumor cell test development firm On-Q-ity has closed its doors, according to a venture capital investor in the firm.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.